Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Treponema pallidum | flavodoxin | 0.0055 | 0.1684 | 0.5 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0144 | 1 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0144 | 1 | 1 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0144 | 1 | 1 |
Trypanosoma brucei | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0064 | 0.2523 | 0.101 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0064 | 0.2523 | 0.101 |
Leishmania major | cytochrome P450 reductase, putative | 0.0128 | 0.8469 | 0.8159 |
Loa Loa (eye worm) | flavodoxin family protein | 0.0055 | 0.1684 | 0.1356 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0128 | 0.8469 | 0.5 |
Leishmania major | p450 reductase, putative | 0.0144 | 1 | 1 |
Brugia malayi | flavodoxin family protein | 0.0055 | 0.1684 | 0.1356 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.216 | 0.1851 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0089 | 0.4848 | 0.4645 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0144 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.0128 | 0.8469 | 0.5 |
Plasmodium vivax | flavodoxin domain containing protein | 0.0128 | 0.8469 | 0.8159 |
Echinococcus multilocularis | methionine synthase reductase | 0.0089 | 0.4848 | 0.4848 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0144 | 1 | 1 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0073 | 0.3317 | 0.3054 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0144 | 1 | 1 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.0128 | 0.8469 | 0.8159 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0144 | 1 | 1 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0144 | 1 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0071 | 0.3215 | 0.5 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0144 | 1 | 1 |
Trypanosoma cruzi | tyrosyl-DNA Phosphodiesterase (Tdp1), putative | 0.0064 | 0.2523 | 0.101 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.216 | 0.1851 |
Echinococcus multilocularis | retinoic acid receptor rxr beta a retinoic acid receptor rxr alpha a retinoic acid receptor rxr alpha | 0.0101 | 0.5995 | 0.5995 |
Echinococcus multilocularis | tyrosyl DNA phosphodiesterase 1 | 0.0064 | 0.2523 | 0.2523 |
Echinococcus granulosus | tyrosyl DNA phosphodiesterase 1 | 0.0064 | 0.2523 | 0.2523 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0144 | 1 | 1 |
Trypanosoma cruzi | p450 reductase, putative | 0.0144 | 1 | 1 |
Schistosoma mansoni | tyrosyl-DNA phosphodiesterase | 0.0064 | 0.2523 | 0.2229 |
Schistosoma mansoni | retinoic acid receptor RXR | 0.0105 | 0.6366 | 0.6222 |
Echinococcus granulosus | retinoic acid receptor rxr beta a | 0.0105 | 0.6366 | 0.6366 |
Echinococcus granulosus | methionine synthase reductase | 0.0089 | 0.4848 | 0.4848 |
Chlamydia trachomatis | sulfite reductase | 0.0089 | 0.4848 | 0.5 |
Schistosoma mansoni | diflavin oxidoreductase | 0.0071 | 0.3215 | 0.2947 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0144 | 1 | 0.5 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0144 | 1 | 1 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0144 | 1 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0089 | 0.4848 | 0.4645 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0144 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0144 | 1 | 1 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0144 | 1 | 1 |
Loa Loa (eye worm) | tyrosyl-DNA phosphodiesterase | 0.0064 | 0.2523 | 0.2229 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0144 | 1 | 1 |
Leishmania major | tyrosyl-DNA phosphodiesterase 1 | 0.0064 | 0.2523 | 0.101 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0071 | 0.3215 | 0.5 |
Brugia malayi | FAD binding domain containing protein | 0.0089 | 0.4848 | 0.4645 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0144 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.216 | 0.1851 |
Brugia malayi | Tyrosyl-DNA phosphodiesterase family protein | 0.0064 | 0.2523 | 0.2229 |
Entamoeba histolytica | tyrosyl-DNA phosphodiesterase, putative | 0.0064 | 0.2523 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.216 | 0.1851 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0144 | 1 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0144 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.1623 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 4.1475 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 5.2213 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | ||
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.